KRON News and Press, Kronos Bio Inc. From 08/04/22

Kronos Bio press release ( NASDAQ: KRON ): Q2 GAAP EPS of -$0.59 beats by $0.10 . $292.4 million in cash, cash equivalents and investments as of June 30, 2022, providing expected cash runway into Q4 2024 For further details see: Kronos Bio  GAAP EPS ...

Company continuing to enroll patients in both Phase 3 registrational AGILITY trial of entospletinib and Phase 1/2 KB-0742 trial; both programs remain on track Preclinical data at EHA further support rationale to develop SYK inhibitors in genetically defined subsets of AML ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you’ve followed the equities sector for a few years now, you’ve almost certainly heard the exhortation not to catch a falling knife. Well, today, we’re going to actively dismiss that notion and consi...

SAN MATEO, Calif. and CAMBRIDGE, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer and other serious diseases, will present preclinical data today from studies of the company’s two novel...

Piper Sandler cut its price target (PT) on 17 companies in the biotech space reflecting the recent pullback in the stock and prevailing market conditions. Piper Sandler also noted that biotech valuations have re-rated. Following are the stocks which saw their PT lowered: Gene editing com...

Kronos Bio (KRON +12.7%) CEO, Norbert Bischofberger bought 597,129 shares at $3.54 - $4.00 worth ~ $2.3M. CEO now owns 809,609 shares. For further details see: Kronos Bio rises 13% as CEO buys shares worth $2.3M

Gainers: Immix Biopharma (IMMX) +48%. MDxHealth (MDXH) +31%. ClearPoint Neuro (CLPT) +16%. Covetrus (CVET) +14%. Kronos Bio (KRON) +13%. Losers: Evofem Biosciences (EVFM) -58%. Bright Green (BGXX) -26%. Foghorn Therapeutics (FHTX) -19%. N...

Siyata Mobile (SYTA) +15%. Covetrus (CVET) +14%. Palo Alto Networks (PANW) +12% on Q3 results. HUTCHMED (HCM) +11%. Team (TISI) +5%. Sono Group (SEV) +8%. Faraday Future Intelligent Electric (FFIE) +7%. NIO (NIO) +7% listed on the Main Board of the Singapore Exchange. iQIY...

Cancer-focused clinical-stage biotech Kronos Bio (NASDAQ:KRON) is trading higher in the pre-market Friday after its President & Chief Executive Officer Norbert Bischofberger disclosed the purchase of about $2.3 million worth of company shares. Bischofberger made the purchase in three sepa...

SAN MATEO, Calif. and CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer and other serious diseases, today announced participation in the H.C. Wainwright Global Investment Conference. ...